This story originally ran on Oct. 29.
Bruker today reported "robust" bookings stemming from global stimulus funding programs as overall revenues rose almost 10 percent during the third quarter.
For the three months ended Sept. 30, the company reported receipts of $265.1 million, up from $242.1 million a year ago. The latter figure treats the Accel RI business, acquired by Bruker in April, as if it were part of Bruker in Q3 2008.
Excluding the effects of currency exchange, revenue in the quarter rose more than 11 percent year over year.